Follow
Anthony Howell, Howell A, Howell T
Anthony Howell, Howell A, Howell T
Professor of Medical Oncology, Manchester University
Verified email at picr.man.ac.uk
Title
Cited by
Cited by
Year
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 365 (9472), 1687-1717, 2005
78872005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
M Clarke, R Collins, S Darby, C Davies, P Elphinstone, E Evans, ...
Lancet 366 (9503), 2087, 2005
62892005
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
41671998
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 …
S Darby, P McGale, C Correa, C Taylor, R Arriagada, M Clarke, D Cutter, ...
Lancet 378 (9804), 1707, 2011
39702011
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
EARLY Breast Cancer TRIALISTS'Collaborative Group
The Lancet 339 (8784), 1-15, 1992
3276*1992
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 365 (9453), 60-62, 2005
31062005
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC …
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, JF Forbes, ...
Lancet 359, 2131-2139, 2005
2674*2005
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, HC Pan, M Clarke, D Cutter, S Darby, ...
Lancet 379 (9814), 432, 2012
22582012
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21581998
Adjuvant docetaxel for node-positive breast cancer
M Martin, T Pienkowski, J Mackey, M Pawlicki, JP Guastalla, C Weaver, ...
New England Journal of Medicine 352 (22), 2302-2313, 2005
13472005
Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials
Early Breast Cancer Trialists’ Collaborative Group
N Engl j med 333 (22), 1444-1455, 1995
12511995
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer journal (Sudbury, Mass.) 7 (5), 377-387, 2001
12202001
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
J Cuzick, I Sestak, M Baum, A Buzdar, A Howell, M Dowsett, JF Forbes
The lancet oncology 11 (12), 1135-1141, 2010
11582010
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or …
LS Rosen, D Gordon, M Kaminski, A Howell, A Belch, J Mackey, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
11142003
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
T Arimidex
The lancet oncology 9 (1), 45-53, 2008
11092008
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
MN Harvie, M Pegington, MP Mattson, J Frystyk, B Dillon, G Evans, ...
International journal of obesity 35 (5), 714-727, 2011
10812011
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ...
The American Journal of Human Genetics 104 (1), 21-34, 2019
9922019
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
J Cuzick, J Forbes, R Edwards, M Baum, S Cawthorn, A Coates, A Hamed, ...
Lancet (London, England) 360 (9336), 817-824, 2002
8962002
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the …
J Cuzick, M Dowsett, S Pineda, C Wale, J Salter, E Quinn, L Zabaglo, ...
Journal of Clinical Oncology 29 (32), 4273-4278, 2011
8922011
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment
A Howell, JFR Robertson, J Quaresma Albano, A Aschermannova, ...
Journal of Clinical Oncology 20 (16), 3396-3403, 2002
8752002
The system can't perform the operation now. Try again later.
Articles 1–20